GRK5 functions as an oncogenic factor in non-small-cell lung cancer.
Cell death & disease
Jiang LP, Fan SQ, Xiong QX, Zhou YC, Yang ZZ, Li GF, Huang YC, Wu MG, Shen QS, Liu K, Yang CP, Chen YB.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2018
Cancer Research
No items found.
Key Finding
The study found that GRK5 expression was significantly increased in 539 NSCLC cancerous tissues than that in 99 normal non-cancerous tissues by immunohistochemistry analysis; the authors also showed intensive higher positive staining percentage in female and adenocarcinoma (ADC) NSCLC patients than that in male and squamous cell carcinoma (SCC) patients, respectively.
Countstar Connection
For the study's cell samples, a Countstar instrument supplied flow-cytometry measurements during the study's migration assessment.
